AMA statement on FDA approval of implant to fight opioid addiction

| 1 Min Read

"The AMA is pleased the FDA approved a new implantable option to help treat patients with substance use disorders. With nearly 2 million Americans needing treatment for opioid use disorder, patients will benefit from increased options for medication-assisted treatment.

 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

U.S. Capitol

In health care’s defining moment, AMA helps drive positive change

| 6 Min Read
Smiling woman sits on couch while typing on laptop

Medicare telehealth coverage renewed for two years

| 5 Min Read
Three businesspeople brainstorming together on a whiteboard in an office

Don’t miss out on this unique physician advocacy fellowship

| 4 Min Read
Child standing in front of a shelf full of fresh products in a supermarket

What doctors wish patients knew about food allergies

| 13 Min Read